• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To register, simply click the Register button at the top right.

ADRA2A and IRX1 are putative risk genes for Raynaud’s phenomenon

SWAlexander

Senior Member
Messages
1,865

Abstract

Raynaud’s phenomenon (RP) is a common vasospastic disorder that causes severe pain and ulcers, but despite its high reported heritability, no causal genes have been robustly identified. We conducted a genome-wide association study including 5,147 RP cases and 439,294 controls, based on diagnoses from electronic health records, and identified three unreported genomic regions associated with the risk of RP (p < 5 × 10−8). We prioritized ADRA2A (rs7090046, odds ratio (OR) per allele: 1.26; 95%-CI: 1.20-1.31; p < 9.6 × 10−27) and IRX1 (rs12653958, OR: 1.17; 95%-CI: 1.12–1.22, p < 4.8 × 10−13) as candidate causal genes through integration of gene expression in disease relevant tissues. We further identified a likely causal detrimental effect of low fasting glucose levels on RP risk (rG = −0.21; p-value = 2.3 × 10−3), and systematically highlighted drug repurposing opportunities, like the antidepressant mirtazapine. Our results provide the first robust evidence for a strong genetic contribution to RP and highlight a so far underrated role of α2A-adrenoreceptor signalling, encoded at ADRA2A, as a possible mechanism for hypersensitivity to catecholamine-induced vasospasms.
Continue: https://www.nature.com/articles/s41467-023-41876-5
 

Garz

Senior Member
Messages
345
many genetic marker studies are like this

authors claim "strong" genetic contribution - but article goes on to detail odds ratios of low 1's

i.e. the chances of persons with this gene allele having the condition are only 1.17-1.31x higher than if they do not

so while humans are complex things - and every individual is different to the next - this being the case we would expect some small genetic contribution to ANY pathological condition - its hardly a smoking gun

for example - any genetic factor that tends to increase an inflammatory response would tend to raise disease risk across a broad spectrum of chronic diseases

but the rarer the condition - i.e. 99,990 out of every 100,000 people do not have the condition - and yet a good number of them do have the allele - the more there needs to be another (or several other) main causal mechanisms involved

this type of context is very often missing from such genetic studies - its left to the reader to unpick - which i find almost intentionally misleading.

or perhaps its a case of - "if you only have a hammer - everything looks like a nail" where our education and scientific institutions reward ultra specialism - rather than cross subject boundary expertise
 
Last edited: